Sign in

CIK 0001042418

  • Non-accelerated filer
  • Smaller reporting company

Inhibitor Therapeutics, Inc.

Sign in to watch
Ticker
INTI
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
541641133
Phone
+1 813-766-2462
Business address
4830 W. KENNEDY BLVD., SUITE 600, TAMPA, FL, 33609
Former names
HedgePath Pharmaceuticals, Inc., COMMONWEALTH BIOTECHNOLOGIES INC
  1. 4/A Open-market sale Controller sold 6,617 shares at $7.50 ($49,628)
  2. 4 Open-market sale Chairman sold 17,700 shares at $6.80 ($120,360)
  3. 4 Open-market sale Controller sold 6,617 shares at $7.50 ($49,628)
  4. 4 Open-market sale President and CEO sold 32,450 shares at $6.87 ($222,932)
  5. 4 Open-market sale Senior Vice Pres/Secretary sold 32,450 shares at $6.87 ($222,932)
  6. 4 Open-market sale Chairman sold 14,300 shares at $7.35 ($105,105)
  7. 4 Open-market sale Director sold 2,442 shares at $10.24 ($25,006)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4/A Open-market sale President and CEO sold 3,000 shares at an average $3.17 ($9,507)
  14. 4/A Open-market sale Secretary and Senior Vice Pres sold 3,000 shares at an average $3.24 ($9,729)
  15. 4/A Open-market sale President and CEO sold 3,000 shares at an average $3.17 ($9,507)
  16. 4 Open-market sale Former Director sold 10,000 shares at an average $2.03 ($20,250)
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 3 Insider Initial Statement of Ownership

Page 11 of 11 · 219 filings